MSH|^~\&|||||20181207073733.994-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||Y93B22^^^NIST-MPI-1^MR||Stonewall^Stinson^Marsden^^^^L|Snohomish^^^^^^M|20170928|M||1002-5^American Indian or Alaska Native^CDCREC|350 Nevada Pl^^Kentwood^MI^49508^USA^P||^PRN^PH^^^616^2047401|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||02^Reminder/recall - any method^HL70215|N|20171207|||A|20170928|20171207
NK1|1|Stonewall^Snohomish^Elizabeth^^^^L|MTH^Mother^HL70063|350 Nevada Pl^^Kentwood^MI^49508^USA^P|^PRN^PH^^^616^2047401
NK1|2|Stonewall^Fremont^William^^^^L|FTH^Father^HL70063|350 Nevada Pl^^Kentwood^MI^49508^USA^P|^PRN^CP^^^616^2047401
ORC|RE|AY93B22.1^NIST-AA-IZ-2|BY93B22.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||49281-0560-05^Pentacel^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||526434|20180104|PMC^Sanofi Pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300017211160720^Polio VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
OBX|5|CE|69764-9^Document Type^LN|4|253088698300006611150402^Haemophilus Influenzae type b VIS^cdcgs1vis||||||F|||20171207
OBX|6|DT|29769-7^Date Vis Presented^LN|4|20171207||||||F|||20171207
OBX|7|CE|69764-9^Document Type^LN|5|253088698300003511070517^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F|||20171207
OBX|8|DT|29769-7^Date Vis Presented^LN|5|20171207||||||F|||20171207
ORC|RE|AY93B22.2^NIST-AA-IZ-2|BY93B22.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||00006-4047-20^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||297961|20180301|MSD^Merck and Co., Inc.^MVX|||CP|A
RXR|C38288^Oral^NCIT
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300019611150415^Rotavirus VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE|AY93B22.3^NIST-AA-IZ-2|BY93B22.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||353480|20180111|PFR^Pfizer, Inc^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300015811151105^Pneumococcal Conjugate (PCV13) VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE||BY93B22.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20170929||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|A
ORC|RE||BY93B22.5^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171028||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|A
MSH|^~\&|||||20181207084727.655-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||R58U24^^^NIST-MPI-1^MR||Haskell^Bindiya^^^^^L||19851128|F||2028-9^Asian^CDCREC|1 Madison Cir^^Huron Township^MI^48164^USA^P||^PRN^PH^^^734^5245497~^NET^^Elise.Wong@isp.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||02^Reminder/recall - any method^HL70215|N|20171207|||A|19851128|20171207
ORC|RE|AR58U24.1^NIST-AA-IZ-2|BR58U24.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||49281-0215-88^TENIVAC^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||315841|20180531|PMC^Sanofi Pasteur^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300028811150224^Tetanus/Diphtheria (Td) VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE||BR58U24.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20170327||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|A
ORC|RE||BR58U24.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20160427||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|A
MSH|^~\&|||||20181207093847.804-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||F94G26^^^NIST-MPI-1^MR||Leslie^Melba^Pantxike^^^^L|Chase^^^^^^M|20060605|F||2106-3^White^CDCREC|133 Navajo St^^Stevensville^MI^49127^USA^P||^PRN^PH^^^269^2672528|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||01^No reminder/recall^HL70215|Y|20171207|||A|20060605|20171207
NK1|1|Leslie^Chase^Michelle^^^^L|MTH^Mother^HL70063|133 Navajo St^^Stevensville^MI^49127^USA^P|^PRN^PH^^^269^2672528
ORC|RE|AF94G26.1^NIST-AA-IZ-2|BF94G26.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||58160-0830-05^CERVARIX^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20180607|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300007311110503^Human papillomavirus Vaccine (Cervarix) VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
MSH|^~\&|||||20150624093847.804-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||F94G26^^^NIST-MPI-1^MR||Leslie^Melba^Pantxike^^^^L|Chase^^^^^^M|20060605|F||2106-3^White^CDCREC|133 Navajo St^^Stevensville^MI^49127^USA^P||^PRN^PH^^^269^2672528|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||01^No reminder/recall^HL70215|Y|20150624|||A|20031221|20150624
NK1|1|Leslie^Chase^Michelle^^^^L|MTH^Mother^HL70063|133 Navajo St^^Stevensville^MI^49127^USA^P|^PRN^PH^^^269^2672528|
ORC|RE|5237^NIST-AA-IZ-2|31309^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362|
RXA|0|1|20171207||58160-0830-05^CERVARIX^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20151223|SKB^GlaxoSmithKline^MVX|||CP|D
RXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20150624
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20150624|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300007311110503^Human papillomavirus Vaccine (Cervarix) VIS^cdcgs1vis||||||F|||20150624
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20150624||||||F|||20150624
MSH|^~\&|||||20181207093847.808-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||C42D29^^^NIST-MPI-1^MR||Morrow^Penrose^Vidya^^^^L||20161115|M||2106-3^White^CDCREC|334 Carter Cir^^Dodgeville^MI^49921^USA^P||^PRN^PH^^^906^6492058|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||N
PD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20171207|||A|20061116|20171207
NK1|1|Morrow^Franklin^Leonard^^^^L|FTH^Father^HL70063|334 Carter Cir^^Dodgeville^MI^49921^USA^P|^PRN^PH^^^906^6492058
ORC|RE|AC42D29.1^NIST-AA-IZ-2|BC42D29.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||58160-0806-01^HIBERIX^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||328734|20180308|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE|AC42D29.2^NIST-AA-IZ-2|BC42D29.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208940|20180705|MSD^Merck and Co., Inc.^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE|AC42D29.3^NIST-AA-IZ-2|BC42D29.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||00006-4681-01^M-M-R II^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||134301|20180412|MSD^Merck and Co., Inc.^MVX|||CP|A
RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300012711120420^Measles/Mumps/Rubella VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
ORC|RE||BC42D29.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|A
MSH|^~\&|||||20181207093847.808-0500||VXU^V04^VXU_V04|2A8p-L.IZ-AD-6|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||
PID|1||P12U31^^^NIST-MPI-1^MR||Freestone^Rawiri^Fodor^^^^L||20161115|M||2106-3^White^CDCREC|207 Vance Cir^^Grand Haven^MI^49417^USA^P||^PRN^PH^^^616^7654616|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||N
PD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20171207|||A|20061116|20171207
NK1|1|Freestone^Hocking^Leonard^^^^L|FTH^Father^HL70063|207 Vance Cir^^Grand Haven^MI^49417^USA^P|^PRN^PH^^^616^7654616
ORC|RE|AP12U31.1^NIST-AA-IZ-2|BP12U31.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20171207||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208490|20180705|MSD^Merck and Co., Inc.^MVX|||CP|U
RXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20171207
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20171207|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20171207
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20171207||||||F|||20171207
